Design, Synthesis, and Pharmacological Characterization of Carbazole Based Dopamine Agonists as Potential Symptomatic and Neuroprotective Therapeutic Agents for Parkinson’s Disease-Reference-Cited by-同舟云学术

Design, Synthesis, and Pharmacological Characterization of Carbazole Based Dopamine Agonists as Potential Symptomatic and Neuroprotective Therapeutic Agents for Parkinson’s Disease

Published:2018-10-09 Issue:1 Volume:10 Page:396-411
ISSN:1948-7193
Container-title:ACS Chemical Neuroscience
language:en
Short-container-title:ACS Chem. Neurosci.

Author:

Elmabruk Asma¹,Das Banibrata¹,Yedlapudi Deepthi¹^ORCID,Xu Liping¹,Antonio Tamara²,Reith Maarten E. A.²,Dutta Aloke K.¹^ORCID

Affiliation:

1. Department of Pharmaceutical Sciences, Wayne State University, Detroit, Michigan 48202, United States

2. Department of Psychiatry, New York University, New York, New York 10016, United States

Funder

National Institute of Neurological Disorders and Stroke

Publisher

American Chemical Society (ACS)

Subject

Cell Biology,Cognitive Neuroscience,Physiology,Biochemistry,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.8b00291

Reference43 articles.

1. Selective neuronal vulnerability in Parkinson disease

2. Neuroprotection in Parkinson Disease

3. Parkinson disease

4. Genetics of Parkinson's Disease

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug Development for Alzheimer’s and Parkinson’s Disease: Where Do We Go Now?;Pharmaceutics;2024-05-24

2. Synthesis of multisubstituted carbazol-4-amines from tetrahydrocarbazol-4-one oximes;Organic Chemistry Frontiers;2024

3. Modulation of Alpha-Synuclein Conformational Ensemble and Aggregation Pathways by Dopamine and Related Molecules;Frontiers in Bioscience-Landmark;2023-10-26

4. Design, synthesis, and biological evaluation of 4-aryl-9H-carbazoles as tubulin polymerization inhibitors with potent anticancer activities;Arabian Journal of Chemistry;2023-10

5. Treatment of Parkinson's Disease: Current Treatments and Recent Therapeutic Developments;Current Drug Discovery Technologies;2023-09